Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial

Paul E. Holtzheimer(Emory University), Helen S. Mayberg(Icahn School of Medicine at Mount Sinai), Parag G. Patil(University of Michigan), Alon Y. Mogilner(NYU Langone Health), Konstantin V. Slavin(University of Illinois Chicago), Julie G. Pilitsis(University of Arizona), Charles DeBattista, DeLea Peichel(St. Jude Medical Center), Randall Espinoza(Neurobehavioral Systems), Ananda K. Pandurangi(Brookdale University Hospital and Medical Center), Georgios Petrides(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Barry R. Rittberg(University of Minnesota), Aviva Abosch(University of Nebraska Medical Center), Joshua A. Berman(Columbia University), Sarah H. Lisanby(National Institute of Mental Health), Robert E. Gross(Rutgers, The State University of New Jersey), Clement Hamani(University Health Network), Louis A. Whitworth(Neurological Surgery), K. Matthews(University of Iowa), Andrés M. Lozano(University of Toronto), Guy M. McKhann(Columbia University Irving Medical Center), Stephan F. Taylor(University of Michigan), Kathryn L. Holloway(Virginia Commonwealth University), Joseph S. Neimat, Anthony J. Rothschild(UMass Memorial Health Care), Shawn M. McClintock(Southwestern Medical Center), Raymond W. Lam(Hong Kong Adventist Hospital), Jaimie M. Henderson(Neurosciences Institute), Christopher R. Honey, Mustafa M. Husain(The University of Texas Southwestern Medical Center)
The Lancet Psychiatry
October 10, 2017
Cited by 565


Related Papers